The Board of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that the following board resolutions have been passed with effect from 1 June 2022: Mr. Wen Deyong has been appointed as the chief executive officer of the Company; Mr. Chen Yuqing has been appointed as the co-chief executive officer of the Company. Mr. Wen Deyong, aged 50, is currently the chief executive officer of the Company and holds directorships and management positions in certain subsidiaries of the Company. Mr. Wen Deyong joined the Group in May 2002 and had worked in Chongqing Yaoyou Pharmaceutical Co., Ltd., a subsidiary of the Company, for an extended period, successively serving as the general manager of the second marketing department, vice president, president and vice chairman, etc.

He served as the vice president of the Company from June 2016 to October 2020, the senior vice president of the Company from October 2020 to January 2022, the co-president of the Company from January 2022 to April 2022, the president of the Company from April 2022 to June 2022, and has served as the chief executive officer of the Company since June 2022. Mr. Wen Deyong is currently a non-executive director of Sinopharm Group Co. Ltd., a company listed on the Hong Kong Stock Exchange, a director of China National Medicines Corporation Ltd., a company listed on the Shanghai Stock Exchange, and the chairman of the supervisory committee of China National Accord Medicines Corporation Ltd., a company listed on the Shenzhen Stock Exchange.

Mr. Wen Deyong was a director of C.Q. Pharmaceutical Holding Co., Ltd., a company listed on the Shenzhen Stock Exchange (stock code: 000950), and a director of Anhui Sunhere Pharmaceutical Excipients Co., Ltd., a company listed on the Shenzhen Stock Exchange. Prior to joining the Group, Mr. Wen Deyong worked in Chongqing Pharmaceutical Co., Ltd. 6th Factory (the predecessor of Chongqing Yaoyou Pharmaceutical Co., Ltd.). Mr. Wen Deyong graduated from West China University of Medical Science (currently West China Medical Center, Sichuan University) majoring in pharmacy and holds a master's degree in business administration from Donghua University.